Inspiration Research Limited (IRL) is an independent company founded in 2003 by Dr. Kenneth Chapman. His vision for Inspiration Research is to educate patients to better manage their diseases and contribute to the advancement of novel therapies. Since inception, Inspiration Research has participated in developing of several leading treatment for asthma and COPD patients, such as Onbrez and Seebri Breezhaler. Currently, IRL specializes in clinical studies with patients diagnosed with asthma, heart disease and COPD. Click here for more information.

In addition, IRL operates a pulmonary function test laboratory that is open on Saturdays. Pulmonary function tests are valuable tools for doctors to diagnose patients with asthma, COPD, and other respiratory disease. Click here for more information.